Sample | Title | Value | Rank |
GSM1116933 | Synovial tissue prior to Tocilizumab therapy, repl 1 | 0.143394 | 76 |
GSM1116935 | Synovial tissue prior to Tocilizumab therapy, repl 2 | -1.08608 | 1 |
GSM1116937 | Synovial tissue prior to Tocilizumab therapy, repl 3 | 0.150837 | 78 |
GSM1116939 | Synovial tissue prior to Tocilizumab therapy, repl 4 | 0.435972 | 96 |
GSM1116941 | Synovial tissue prior to Tocilizumab therapy, repl 5 | 0.187081 | 84 |
GSM1116943 | Synovial tissue prior to Tocilizumab therapy, repl 6 | 0.431182 | 94 |
GSM1116945 | Synovial tissue prior to Tocilizumab therapy, repl 7 | -0.646619 | 6 |
GSM1116947 | Synovial tissue prior to Tocilizumab therapy, repl 8 | 0.468618 | 95 |
GSM1116949 | Synovial tissue prior to Tocilizumab therapy, repl 9 | 0.464469 | 96 |
GSM1116951 | Synovial tissue prior to Tocilizumab therapy, repl 10 | -0.315961 | 7 |
GSM1116953 | Synovial tissue prior to Tocilizumab therapy, repl 11 | -0.411034 | 5 |
GSM1116955 | Synovial tissue prior to Tocilizumab therapy, repl 12 | -1.0096 | 1 |
GSM1116934 | Synovial tissue after to Tocilizumab therapy, repl 1 | 3.6292 | 99 |
GSM1116936 | Synovial tissue after to Tocilizumab therapy, repl 2 | 2.71265 | 99 |
GSM1116938 | Synovial tissue after to Tocilizumab therapy, repl 3 | -0.0251331 | 43 |
GSM1116940 | Synovial tissue after to Tocilizumab therapy, repl 4 | 1.4453 | 99 |
GSM1116942 | Synovial tissue after to Tocilizumab therapy, repl 5 | 0.180485 | 84 |
GSM1116944 | Synovial tissue after to Tocilizumab therapy, repl 6 | -0.715527 | 1 |
GSM1116946 | Synovial tissue after to Tocilizumab therapy, repl 7 | -0.756906 | 2 |
GSM1116948 | Synovial tissue after to Tocilizumab therapy, repl 8 | 1.82427 | 99 |
GSM1116950 | Synovial tissue after to Tocilizumab therapy, repl 9 | 0.350337 | 91 |
GSM1116952 | Synovial tissue after to Tocilizumab therapy, repl 10 | -0.23243 | 11 |
GSM1116954 | Synovial tissue after to Tocilizumab therapy, repl 11 | 0.0516376 | 63 |
GSM1116956 | Synovial tissue after to Tocilizumab therapy, repl 12 | -0.470024 | 3 |